|
1
|
Tung-Ping PR, Fan ST and Wong J: Risk
factors, prevention and management of postoperative recurrence
after resection of hepatocellular carcinoma. Ann Surg. 232:10–24.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thomas MB and Zhu AX: Hepatocellular
carcinoma: the need for progress. J Clin Oncol. 23:2892–2899. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jacobs JJ and van Lohuizen M: Polycomb
repression: from cellular memory to cellular proliferation and
cancer. Biochim Biophys Acta. 1602:151–161. 2002.PubMed/NCBI
|
|
4
|
Kondo Y, Shen L, Cheng AS, et al: Gene
silencing in cancer by histone H3 lysine 27 trimethylation
independent of promoter DNA methylation. Nat Genet. 40:741–750.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raaphorst FM: Deregulated expression of
Polycomb-group oncogenes in human malignant lymphomas and
epithelial tumors. Hum Mol Genet. 14:R93–R100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Lohuizen M, Verbeek S, Scheijen B,
Wientjens E, van der Gulden H and Berns A: Identification of
cooperating oncogenes in E mu-myc transgenic mice by provirus
tagging. Cell. 65:737–752. 1991.PubMed/NCBI
|
|
7
|
Liu S, Dontu G, Mantle ID, et al: Hedgehog
signaling and Bmi-1 regulate self-renewal of normal and malignant
human mammary stem cells. Cancer Res. 66:6063–6071. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jacobs JJ, Kieboom K, Marino S, DePinho RA
and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1
regulates cell proliferation and senescence through the ink4a
locus. Nature. 397:164–168. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dimri GP, Martinez JL, Jacobs JJ, et al:
The Bmi-1 oncogene induces telomerase activity and immortalizes
human mammary epithelial cells. Cancer Res. 62:4736–4745.
2002.PubMed/NCBI
|
|
10
|
Mihic-Probst D, Kuster A, Kilgus S, et al:
Consistent expression of the stem cell renewal factor BMI-1 in
primary and metastatic melanoma. Int J Cancer. 121:1764–1770. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JH, Yoon SY, Jeong SH, et al:
Overexpression of Bmi-1 oncoprotein correlates with axillary lymph
node metastases in invasive ductal breast cancer. Breast.
13:383–388. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin ZK, Yang JA, Ye YL, et al: Expression
of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer.
9:612009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song W, Tao K, Li H, et al: Bmi-1 is
related to proliferation, survival and poor prognosis in pancreatic
cancer. Cancer Sci. 101:1754–1760. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Effendi K, Mori T, Komuta M, Masugi Y, Du
W and Sakamoto M: Bmi-1 gene is upregulated in early-stage
hepatocellular carcinoma and correlates with ATP-binding cassette
transporter B1 expression. Cancer Sci. 101:666–672. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sasaki M, Ikeda H, Itatsu K, et al: The
overexpression of polycomb group proteins Bmi1 and EZH2 is
associated with the progression and aggressive biological behavior
of hepatocellular carcinoma. Lab Invest. 88:873–882. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Pan K, Zhang HK, et al: Increased
polycomb-group oncogene Bmi-1 expression correlates with poor
prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol.
134:535–541. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sparmann A and van Lohuizen M: Polycomb
silencers control cell fate, development and cancer. Nat Rev
Cancer. 6:846–856. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li DW, Tang HM, Fan JW, et al: Expression
level of Bmi-1 oncoprotein is associated with progression and
prognosis in colon cancer. J Cancer Res Clin Oncol. 136:997–1006.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu JH, Song LB, Zhang X, et al: Bmi-1
expression predicts prognosis for patients with gastric carcinoma.
J Surg Oncol. 97:267–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song LB, Zeng MS, Liao WT, et al: Bmi-1 is
a novel molecular marker of nasopharyngeal carcinoma progression
and immortalizes primary human nasopharyngeal epithelial cells.
Cancer Res. 66:6225–6232. 2006. View Article : Google Scholar
|
|
21
|
Jiang Y, Su B, Meng X, et al: Effect of
siRNA-mediated silencing of Bmi-1 gene expression on HeLa cells.
Cancer Sci. 101:379–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: Downregulation of the Notch signaling pathway inhibits
hepatocellular carcinoma cell invasion by inactivation of matrix
metalloproteinase-2 and -9 and vascular endothelial growth factor.
Oncol Rep. 28:874–882. 2012.
|
|
23
|
Zheng H, Takahashi H, Murai Y, et al:
Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth,
invasion, metastasis and angiogenesis of gastric carcinoma.
Anticancer Res. 26:3579–3583. 2006.PubMed/NCBI
|
|
24
|
Song LB, Li J, Liao WT, et al: The
polycomb group protein Bmi-1 represses the tumour suppressor PTEN
and induces epithelial-mesenchymal transition in human
nasopharyngeal epithelial cells. J Clin Invest. 119:3626–3636.
2009. View
Article : Google Scholar
|
|
25
|
Pore N, Liu S, Haas-Kogan DA, O’Rourke DM
and Maity A: PTEN mutation and epidermal growth factor receptor
activation regulate vascular endothelial growth factor (VEGF) mRNA
expression in human glioblastoma cells by transactivating the
proximal VEGF promoter. Cancer Res. 63:236–241. 2003.
|
|
26
|
Liu B, Wu X, Liu B, et al: MiR-26a
enhances metastasis potential of lung cancer cells via AKT pathway
by targeting PTEN. Biochim Biophys Acta. 1822:1692–1704. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen JS, Wang Q, Fu XH, et al: Involvement
of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gomaa AI, Khan SA, Toledano MB, Waked I
and Taylor-Robinson SD: Hepatocellular carcinoma: epidemiology,
risk factors and pathogenesis. World J Gastroenterol. 14:4300–4308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo BH, Feng Y, Zhang R, et al: Bmi-1
promotes invasion and metastasis and its elevated expression is
correlated with an advanced stage of breast cancer. Mol Cancer.
10:102011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoenerhoff MJ, Chu I, Barkan D, et al:
BMI1 cooperates with H-RAS to induce an aggressive breast cancer
phenotype with brain metastases. Oncogene. 28:3022–3032. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
32
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fingleton B: Matrix metalloproteinases:
roles in cancer and metastasis. Front Biosci. 11:479–491. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Q, Chen X, Zhou J, et al: CD147,
MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence
after liver transplantation in hepatocellular carcinoma patients.
Cancer Biol Ther. 5:808–814. 2006. View Article : Google Scholar
|
|
35
|
Giannelli G, Bergamini C, Marinosci F, et
al: Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular
carcinoma. Int J Cancer. 97:425–431. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wey JS, Fan F, Gray MJ, et al: Vascular
endothelial growth factor receptor-1 promotes migration and
invasion in pancreatic carcinoma cell lines. Cancer. 104:427–438.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Meng X, Wang Y, Zheng X, et al:
shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell
migration and metastasis. Lung Cancer. 77:24–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jiang L, Wu J, Yang Y, et al: Bmi-1
promotes the aggressiveness of glioma via activating the
NF-kappaB/MMP-9 signaling pathway. BMC Cancer. 12:4062012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chalhoub N and Baker SJ: PTEN and the
PI3-kinase pathway in cancer. Annu Rev Pathol. 4:127–150. 2009.
View Article : Google Scholar : PubMed/NCBI
|
